+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07017517

Study of Physical Therapy Effects on Muscle Inflammation and Weakness in Critical Illness Myopathy Patients in ICU

Led by University of Chile · Updated on 2026-05-06

24

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are exploring whether physical therapy can reduce activation of the NLRP3 inflammasome and muscle wasting in patients with critical illness myopathy CIM, a common complication in intensive care units causing muscle weakness and long-term disability. This trial aims to understand the role of the NLRP3 inflammasome in CIM and whether physical therapy can help prevent or reduce muscle loss by affecting related gene activity. The study compares two types of physical therapy for critically ill patients at risk of CIM during early ICU stay. One group receives standard physiotherapy, while the other group gets enhanced therapy including twice-daily 60-minute sessions of servo-assisted cycling using the Motomed Letto device for 7 consecutive days. Additionally, a control group of patients without CIM will be included for comparison. Muscle biopsies and blood samples will be collected to analyze molecular markers related to muscle atrophy and inflammasome activity. Participants will undergo clinical evaluations using muscle ultrasound and the SOFA scale to diagnose CIM. Muscle strength and physical function will be tracked over time, alongside molecular and gene expression analyses from tissue samples taken at the start and end of the intervention. Researchers will monitor changes in muscle structure and inflammation markers to assess the impact of physical therapy. Sociodemographic and clinical information will also be recorded during the study period, which extends through recovery and follow-up.

CONDITIONS

Brief Title

NLRP3 Inflammasome and Physical Therapy in ICU-Acquired Weakness

Research Team

Ó

Óscar L Arellano-Pérez, MSc.

P

Paola A Llanos, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here